Chemistry:Diclazafone desglycyl
From HandWiki
| File:Diclazafone-desglycyl structure.png | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C15H12Cl2N2O2 |
| Molar mass | 323.17 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Diclazafone desglycyl is a chemical compound that can act as both a prodrug and a synthetic precursor for the benzodiazepine derivative delorazepam, the N-desmethyl derivative of the designer benzodiazepine diclazepam. It is inactive in vitro but has similar effects to delorazepam in vivo due to metabolic conversion to the active benzodiazepine form.[1] It has been detected as a designer drug, first being identified in Denmark in September 2024.[2]
See also
References
- ↑ "Quinazolines and 1,4-benzodiazepines. 90. Structure-activity relationship between substituted 2-amino-N-(2-benzoyl-4-chlorophenyl)acetamides and 1,4-benzodiazepinones". Journal of Medicinal Chemistry 25 (9): 1050–1055. September 1982. doi:10.1021/jm00351a009. PMID 6127410.
- ↑ "European Drug Report 2025 – Full Book". European Union Drugs Agency (euda.europa.eu). 6 June 2025. https://www.euda.europa.eu/system/files/documents/2025-06/edr-2025-full-book-6.06.2025-en.pdf.
 |  |
